| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,575 |
1,395 |
$235K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
531 |
421 |
$106K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,975 |
1,374 |
$99K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
831 |
733 |
$87K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
499 |
428 |
$65K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
100 |
66 |
$45K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,694 |
985 |
$43K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,493 |
503 |
$42K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,089 |
865 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
487 |
404 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,806 |
3,989 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
81 |
76 |
$25K |
| 70450 |
Computed tomography, head or brain; without contrast material |
134 |
113 |
$22K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
332 |
207 |
$18K |
| 97161 |
|
222 |
150 |
$18K |
| 80053 |
Comprehensive metabolic panel |
2,179 |
1,637 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
63 |
40 |
$16K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
43 |
25 |
$16K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
15 |
12 |
$15K |
| 73630 |
|
204 |
166 |
$14K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
211 |
173 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,174 |
957 |
$13K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
37 |
30 |
$12K |
| G0378 |
Hospital observation service, per hour |
61 |
13 |
$12K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
39 |
27 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
288 |
229 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
354 |
253 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
138 |
93 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
109 |
74 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
289 |
194 |
$9K |
| 73610 |
|
135 |
107 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
199 |
162 |
$8K |
| 73562 |
|
101 |
90 |
$8K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
96 |
43 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
175 |
130 |
$7K |
| 80061 |
Lipid panel |
674 |
538 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
341 |
244 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
340 |
243 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,149 |
894 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
217 |
216 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
816 |
652 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
282 |
233 |
$6K |
| 87800 |
|
238 |
155 |
$5K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
184 |
140 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
219 |
81 |
$5K |
| 96376 |
|
80 |
41 |
$5K |
| 87806 |
|
250 |
193 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
109 |
74 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
112 |
88 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
5,148 |
4,135 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
173 |
119 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
62 |
47 |
$4K |
| 73030 |
|
60 |
49 |
$4K |
| 84702 |
|
269 |
186 |
$3K |
| 86803 |
|
270 |
210 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
135 |
125 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
184 |
110 |
$3K |
| 73130 |
|
60 |
42 |
$3K |
| 85027 |
|
501 |
383 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
135 |
82 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
102 |
74 |
$2K |
| 82728 |
|
208 |
179 |
$2K |
| 72100 |
|
28 |
25 |
$2K |
| 73110 |
|
40 |
28 |
$2K |
| 74018 |
|
46 |
39 |
$2K |
| 84484 |
|
266 |
166 |
$2K |
| 84439 |
|
273 |
210 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
359 |
284 |
$2K |
| 82607 |
|
173 |
144 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
15 |
$2K |
| 11721 |
|
113 |
92 |
$2K |
| 83880 |
|
82 |
60 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
84 |
36 |
$2K |
| 83655 |
|
154 |
121 |
$2K |
| 80306 |
|
166 |
132 |
$2K |
| 86850 |
|
161 |
119 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
239 |
167 |
$1K |
| 73100 |
|
49 |
25 |
$1K |
| 83690 |
|
288 |
206 |
$1K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
82 |
67 |
$1K |
| 86780 |
|
114 |
86 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
30 |
$1K |
| 86140 |
|
291 |
223 |
$1K |
| 83550 |
|
172 |
147 |
$1K |
| 83735 |
|
238 |
165 |
$1K |
| 87186 |
|
154 |
130 |
$1K |
| 80076 |
|
181 |
160 |
$1K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
36 |
16 |
$1K |
| 82962 |
|
295 |
110 |
$1K |
| 81001 |
|
471 |
352 |
$1K |
| 83516 |
|
99 |
73 |
$1K |
| 84403 |
|
47 |
34 |
$1K |
| 84146 |
|
67 |
44 |
$981.76 |
| 87340 |
|
120 |
87 |
$976.99 |
| 82784 |
|
97 |
71 |
$958.68 |
| 81025 |
|
190 |
148 |
$910.10 |
| 82803 |
|
49 |
40 |
$896.65 |
| 85610 |
|
312 |
204 |
$864.07 |
| 87430 |
|
87 |
66 |
$854.50 |
| 83540 |
|
172 |
147 |
$843.99 |
| 80050 |
General health panel |
104 |
100 |
$792.32 |
| 82570 |
|
176 |
132 |
$746.95 |
| 87040 |
|
47 |
41 |
$744.58 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
526 |
367 |
$741.23 |
| 87070 |
|
93 |
68 |
$689.10 |
| 83605 |
|
88 |
61 |
$686.29 |
| 84153 |
|
59 |
42 |
$659.92 |
| 73140 |
|
12 |
12 |
$648.31 |
| 86039 |
|
75 |
53 |
$627.44 |
| 85379 |
|
81 |
65 |
$598.53 |
| 85652 |
|
286 |
213 |
$584.62 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
15 |
15 |
$580.70 |
| 86618 |
|
49 |
43 |
$561.49 |
| 86787 |
|
54 |
40 |
$559.35 |
| 82043 |
|
137 |
99 |
$551.01 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
24 |
12 |
$464.03 |
| 86900 |
|
166 |
122 |
$451.38 |
| 86762 |
|
37 |
24 |
$396.83 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
166 |
130 |
$383.81 |
| 86901 |
|
166 |
122 |
$378.51 |
| 81003 |
|
283 |
211 |
$365.18 |
| 87147 |
|
43 |
29 |
$355.35 |
| 84460 |
|
78 |
69 |
$329.48 |
| 87205 |
|
89 |
66 |
$321.98 |
| J7050 |
Infusion, normal saline solution, 250 cc |
259 |
145 |
$301.60 |
| 82670 |
|
14 |
12 |
$286.84 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
244 |
173 |
$255.36 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
224 |
147 |
$249.68 |
| 82565 |
|
65 |
54 |
$228.04 |
| 85730 |
|
48 |
42 |
$218.12 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
243 |
181 |
$209.50 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
12 |
$203.52 |
| 86706 |
|
20 |
13 |
$198.57 |
| 84100 |
|
54 |
41 |
$184.76 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
74 |
49 |
$162.54 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
272 |
190 |
$144.16 |
| J2704 |
Injection, propofol, 10 mg |
58 |
42 |
$140.97 |
| 84450 |
|
32 |
28 |
$129.78 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
57 |
28 |
$101.80 |
| 82550 |
|
16 |
12 |
$99.64 |
| 86431 |
|
27 |
13 |
$91.04 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
321 |
219 |
$89.13 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
199 |
145 |
$87.67 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
29 |
15 |
$56.23 |
| 84550 |
|
29 |
14 |
$55.97 |
| 82950 |
|
14 |
14 |
$52.86 |
| 82947 |
|
15 |
14 |
$40.08 |
| 84132 |
|
12 |
12 |
$35.42 |
| J2060 |
Injection, lorazepam, 2 mg |
64 |
40 |
$25.26 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
13 |
12 |
$22.85 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
12 |
12 |
$12.80 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
22 |
12 |
$12.54 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
27 |
12 |
$1.52 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
103 |
68 |
$0.00 |